Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

26,321 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficiency and Tolerability of Induction and Consolidation Therapy with Arsenic Trioxide/Bortezomib/Ascorbic Acid/Dexamethasone (ABCD) Regimen Compared to Bortezomib/Dexamethasone (BD) Regimen in Newly Diagnosed Myeloma Patients.
Qian W, Wang L, Li P, Hu Y, Wang Q, Yi K, Wu M, Xu Y, Song J, Chen P, Zhang H, Ma J, Xie Y. Qian W, et al. Among authors: wu m. Cancer Manag Res. 2020 Jan 20;12:431-441. doi: 10.2147/CMAR.S212455. eCollection 2020. Cancer Manag Res. 2020. PMID: 32021455 Free PMC article.
[Comparison of the Curative Efficacy of Elderly Patients with High-Risk MDS and MDS-Transformed AML between Decitabine Combined with Low-Dose CEG Regimen and Decitabine Combined with Low-Dose CAG Regimen].
Wu M, Ma IX, Xie YH, Ye XJ, He HS, Hua JS, Yang RY, Wang XH, Wang XQ, Li F. Wu M, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2020 Dec;28(6):1991-1997. doi: 10.19746/j.cnki.issn.1009-2137.2020.06.032. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2020. PMID: 33283731 Clinical Trial. Chinese.
26,321 results
You have reached the last available page of results. Please see the User Guide for more information.